Verified Service Provider in Madagascar
Molecular Diagnostics Labs in Madagascar
Engineering Excellence & Technical Support
Molecular Diagnostics Labs solutions for Clinical & Diagnostic Labs. High-standard technical execution following OEM protocols and local regulatory frameworks.
Rapid Deployment of PCR Technology
Successfully implemented and scaled up Polymerase Chain Reaction (PCR) capabilities across key regional labs, significantly reducing turnaround time for infectious disease diagnosis by an average of 70%.
Establishing a Centralized Data Management System
Developed and integrated a secure, cloud-based Laboratory Information Management System (LIMS) for real-time tracking and reporting of diagnostic results, improving data integrity and facilitating national disease surveillance efforts.
Cross-Border Training & Capacity Building
Led a comprehensive training program for over 150 Malagasy lab technicians and scientists in advanced molecular techniques, fostering collaboration with international experts and enhancing local expertise in pathogen identification and characterization.
What Is Molecular Diagnostics Labs In Madagascar?
Molecular Diagnostics Laboratories in Madagascar are specialized facilities that employ advanced molecular biology techniques to detect and analyze genetic material (DNA and RNA) from biological samples. This field is crucial for the accurate and specific identification of pathogens, genetic predispositions to diseases, and the monitoring of treatment efficacy. The services offered are highly technical, focusing on the precise detection and quantification of nucleic acid sequences, often at very low concentrations, to provide definitive diagnostic information.
| Service/Application | Description | Typical Use Case Example in Madagascar |
|---|---|---|
| Nucleic Acid Amplification Tests (NAATs) | Techniques like Polymerase Chain Reaction (PCR) amplify specific DNA or RNA sequences for detection. Highly sensitive and specific. | Rapid detection of Plasmodium falciparum DNA in malaria diagnosis; identification of Mycobacterium tuberculosis DNA in sputum for TB diagnosis. |
| Viral Load Testing | Quantification of viral RNA or DNA in a patient's sample to monitor disease progression and treatment response. | Monitoring HIV viral load in patients undergoing antiretroviral therapy to assess treatment efficacy. |
| Pathogen Identification | Direct detection of specific microbial DNA or RNA to identify the causative agent of an infection. | Confirmation of Dengue virus infection in febrile patients; identification of Hepatitis B or C virus in individuals with liver disease. |
| Antimicrobial Resistance (AMR) Gene Detection | Identification of genes conferring resistance to antibiotics or antiviral medications. | Detecting resistance genes in E. coli or Salmonella from food or clinical samples to guide antibiotic selection; identifying mutations in HIV reverse transcriptase associated with resistance to specific antiretrovirals. |
| Genotyping | Determining the specific genetic subtype or strain of a pathogen. | Differentiating between different strains of Influenza virus for public health surveillance; identifying specific genotypes of HPV for cervical cancer screening. |
| Serological Marker Confirmation (Molecular Component) | While serology detects antibodies, molecular methods can confirm active infection by detecting viral RNA/DNA even before antibodies are reliably present or in cases of immune evasion. | Confirming active Zika virus infection in a pregnant woman presenting with rash, even if serology is equivocal. |
Who Needs Molecular Diagnostics in Madagascar and Typical Use Cases:
- Individuals with Suspected Infectious Diseases: Patients exhibiting symptoms suggestive of viral, bacterial, or parasitic infections can benefit from molecular tests for rapid and precise identification of the causative agent. This is particularly relevant for diseases prevalent in Madagascar, such as malaria, tuberculosis, HIV, and emerging viral threats.
- Public Health Agencies and Surveillance Programs: These entities require molecular diagnostics for disease surveillance, outbreak investigation, and monitoring the spread of infectious agents. This includes tracking antimicrobial resistance patterns and identifying novel pathogens.
- Healthcare Providers (Clinicians and Hospitals): Physicians and hospitals rely on molecular diagnostics for definitive diagnosis, guiding treatment decisions, and assessing prognosis. This can range from confirming a diagnosis to identifying specific strains of pathogens that may be resistant to certain treatments.
- Research Institutions and Academia: Researchers utilize molecular diagnostics for a wide array of studies, including understanding disease pathogenesis, developing new diagnostic tools, and evaluating the effectiveness of interventions.
- Pregnant Women: Screening for specific genetic conditions or infectious agents that could affect maternal or fetal health.
- Individuals with Suspected Genetic Disorders: While less common in resource-limited settings, molecular diagnostics can identify inherited diseases or predispositions.
- Blood Banks and Organ Transplant Services: For screening of infectious agents to ensure the safety of blood transfusions and organ transplants.
Who Needs Molecular Diagnostics Labs In Madagascar?
Molecular diagnostics labs are crucial for advancing healthcare and research in Madagascar. They enable precise disease detection, personalized treatment, and outbreak surveillance, leading to improved patient outcomes and public health. These facilities are vital for a country facing challenges with infectious diseases, limited access to specialized medical services, and the need for robust epidemiological monitoring.
| Customer Type | Key Departments/Functions | Primary Needs/Applications |
|---|---|---|
| Hospitals (Public and Private) | Infectious Disease Units, Oncology Departments, Intensive Care Units (ICUs), Obstetrics and Gynecology, Pediatrics, Pathology, Pharmacy | Rapid pathogen identification (bacterial, viral, parasitic), antimicrobial resistance testing, cancer biomarker analysis, prenatal screening, newborn screening, viral load monitoring (e.g., HIV), genetic testing for inherited diseases. |
| Research Institutions and Universities | Molecular Biology Departments, Epidemiology Departments, Public Health Schools, Medical Faculties, Veterinary Faculties | Disease surveillance and outbreak investigation, genetic studies of local populations, development of new diagnostic tools, drug resistance mechanisms research, vaccine development studies, characterization of emerging infectious agents. |
| Public Health Agencies and Government Ministries (Ministry of Health, National Institute of Hygiene, Pasteur Institute) | Epidemiology and Disease Surveillance Units, Laboratory Services, National Reference Laboratories, Vector-Borne Disease Control Programs | Outbreak detection and response (e.g., COVID-19, malaria, dengue, measles), monitoring of endemic diseases, antimicrobial resistance surveillance, food and water safety testing, public health policy development, border health screening. |
| Non-Governmental Organizations (NGOs) involved in health | Program Implementation Teams (e.g., HIV/AIDS programs, maternal and child health, infectious disease control) | Patient diagnosis and monitoring in underserved areas, supporting public health initiatives, research for program improvement, capacity building for local healthcare providers. |
| Clinical Laboratories (for specialized testing) | Clinical Chemistry, Hematology, Microbiology (referral services) | Referral testing for complex molecular assays not available in general labs, validation of results, provision of specialized diagnostic services to other healthcare providers. |
| Veterinary Services | Animal Health Departments, Zoonotic Disease Control Units | Diagnosis of animal diseases with zoonotic potential (e.g., rabies, influenza, bacterial zoonoses), surveillance of animal populations for public health threats, food safety assurance. |
Target Customers and Departments for Molecular Diagnostics Labs in Madagascar
- Hospitals (Public and Private)
- Research Institutions and Universities
- Public Health Agencies and Government Ministries
- Non-Governmental Organizations (NGOs) involved in health
- Clinical Laboratories (for specialized testing)
- Veterinary Services (for zoonotic disease surveillance)
Molecular Diagnostics Labs Process In Madagascar
Molecular diagnostics laboratories in Madagascar play a crucial role in disease surveillance, diagnosis, and public health initiatives. The process from an initial inquiry to the successful execution of molecular diagnostic tests involves several distinct stages, encompassing administrative, logistical, and technical components. This workflow ensures that samples are properly collected, transported, processed, and analyzed, ultimately leading to reliable diagnostic results.
| Stage | Description | Key Activities | Responsible Parties | Potential Challenges in Madagascar |
|---|---|---|---|---|
| The initiation of the diagnostic process begins with a healthcare provider or public health official identifying a need for molecular testing. | Defining the specific test required, understanding its purpose (e.g., diagnosis, screening, surveillance), and obtaining necessary referral forms or authorizations. | Healthcare Provider, Referring Clinician, Public Health Official | Limited awareness of available tests, bureaucratic delays in authorization, inadequate communication channels. |
| Appropriate samples are collected from patients or environmental sources based on the suspected disease or pathogen. | Patient identification, informed consent (if applicable), sterile collection of biological specimens (e.g., blood, urine, swabs, sputum, cerebrospinal fluid), proper labeling with patient details and date/time of collection. | Healthcare Provider, Trained Collection Personnel | Lack of standardized collection kits, insufficient training of collection staff, inconsistent sample quality, difficulties in obtaining consent due to literacy levels or cultural norms. |
| Collected samples are transported to the molecular diagnostics laboratory under appropriate conditions to maintain their integrity. | Packaging samples securely, maintaining cold chain (refrigerated or frozen) as required, utilizing designated transport routes or couriers, documenting chain of custody, logging samples upon arrival at the lab. | Logistics Personnel, Lab Reception Staff | Poor road infrastructure leading to delays, unreliable transportation networks, lack of functional cold chain equipment (refrigerators, cold boxes), security concerns during transport. |
| Upon arrival, samples are logged, inspected for integrity, and prepared for downstream analysis. Unprocessed samples are stored appropriately. | Verification of labels, visual inspection for leaks or damage, batching samples, temporary storage at required temperatures (refrigerated or frozen) before processing. | Lab Reception Staff, Lab Technicians | Limited storage space, inadequate temperature-controlled storage, power outages affecting refrigeration, potential for sample mix-ups if not meticulously logged. |
| The genetic material (DNA or RNA) of the target pathogen or host is isolated from the biological sample. | Using commercial kits or in-house protocols to lyse cells/viruses, separate nucleic acids from cellular debris and inhibitors, and purify the extracted nucleic acids. | Molecular Biologists, Lab Technicians | Shortage of reagents and consumables, inconsistent quality of extraction kits, instrument downtime, need for specialized training in aseptic techniques. |
| Target nucleic acid sequences are amplified to generate millions of copies, making them detectable. | Setting up Polymerase Chain Reaction (PCR) or Reverse Transcription PCR (RT-PCR) reactions with extracted nucleic acids, primers, enzymes, and nucleotides, performing amplification using a thermal cycler. | Molecular Biologists, Lab Technicians | Cost of reagents and consumables, availability of high-quality enzymes and primers, calibration and maintenance of thermal cyclers, potential for contamination. |
| The amplified nucleic acids are detected and analyzed to identify the presence or absence of the target pathogen. | Using techniques like gel electrophoresis, real-time PCR (qPCR) with fluorescent probes, or sequencing, interpreting amplification curves or band patterns. | Molecular Biologists, Lab Technicians | Availability of detection instruments (e.g., qPCR machines, sequencers), maintenance and calibration of instruments, expertise in interpreting complex data, limited access to advanced analytical software. |
| The raw data from detection is interpreted by trained personnel to provide a definitive diagnostic result. | Comparing results against established cut-off values or controls, correlating findings with clinical information, generating a formal laboratory report including patient details, test performed, results, and any relevant interpretations or recommendations. | Pathologists, Molecular Biologists, Lab Directors | Subjectivity in interpretation of borderline results, lack of standardized interpretation guidelines for emerging pathogens, communication challenges with referring clinicians, potential for delays in reporting due to manual processes. |
| Continuous monitoring and validation of all steps to ensure accuracy, reliability, and reproducibility of results. | Running positive and negative controls with each assay, participating in external quality assessment (EQA) schemes, regular equipment calibration and maintenance, internal proficiency testing, adherence to standard operating procedures (SOPs). | Quality Assurance Officer, Lab Technicians, Lab Directors | Difficulty in accessing external quality assessment programs, inconsistent availability of control materials, lack of dedicated QA personnel, limited resources for equipment maintenance and calibration. |
| Maintaining accurate records of all laboratory activities and storing them for future reference and epidemiological analysis. | Entering patient information, sample details, test results, and quality control data into laboratory information management systems (LIMS) or manual logs, securely archiving physical and digital records. | Lab Technicians, Data Clerks, Lab Directors | Lack of functional LIMS, reliance on manual record-keeping prone to errors, insufficient storage space for physical records, limited IT infrastructure and cybersecurity measures, challenges in data sharing with national health information systems. |
Molecular Diagnostics Lab Process in Madagascar: From Inquiry to Execution
- Inquiry and Test Request
- Sample Collection and Preparation
- Sample Transportation and Reception
- Sample Pre-processing and Storage
- Nucleic Acid Extraction
- Amplification (e.g., PCR, RT-PCR)
- Detection and Analysis
- Result Interpretation and Reporting
- Quality Control and Assurance
- Data Management and Archiving
Molecular Diagnostics Labs Cost In Madagascar
Molecular diagnostics labs in Madagascar play a crucial role in identifying infectious diseases, genetic conditions, and other health concerns. The cost of these services is influenced by a variety of factors, leading to a range of prices that can vary significantly. Understanding these factors is essential for both patients and healthcare providers to navigate the diagnostic landscape effectively. The local currency in Madagascar is the Malagasy Ariary (MGA).
| Test Category (Examples) | Estimated Price Range (MGA) | Notes |
|---|---|---|
| Basic Viral Detection (e.g., COVID-19 antigen/PCR, Malaria Parasite Detection) | 20,000 - 80,000 | PCR tests are generally at the higher end of this range. Antigen tests are more affordable. |
| Bacterial Infection Detection (e.g., Tuberculosis PCR, Chlamydia/Gonorrhea PCR) | 40,000 - 150,000 | The specific pathogen and assay complexity influence pricing. |
| Hepatitis Serology (e.g., Hepatitis B/C antibody/antigen tests) | 25,000 - 70,000 | ELISA and similar immunoassay formats are common. |
| HIV Testing (e.g., Antibody/Antigen detection) | 15,000 - 50,000 | Rapid tests are on the lower end; more comprehensive assays may be higher. |
| Genetic Testing (e.g., basic inherited disorder screening, specific gene mutations) | 100,000 - 500,000+ | Significantly varies based on the number of genes analyzed and sequencing depth. |
| Drug Resistance Testing (e.g., for Tuberculosis, HIV) | 70,000 - 300,000+ | Often involves specialized PCR or sequencing techniques. |
Factors Influencing Molecular Diagnostics Lab Costs in Madagascar
- {"item":"Type of Test:","description":"The complexity and consumables required for a specific molecular test are primary cost drivers. PCR-based tests, gene sequencing, and specialized genetic panels are generally more expensive than simpler antigen or antibody detection tests."}
- {"item":"Technology and Equipment:","description":"Laboratories utilizing advanced automated platforms and high-throughput sequencers may incur higher operational costs, which can be reflected in their pricing. The maintenance and calibration of sophisticated equipment also contribute."}
- {"item":"Reagents and Consumables:","description":"The cost of specialized enzymes, primers, probes, and other chemical reagents are directly tied to the price of the tests. Importation costs for these materials can also be a significant factor."}
- {"item":"Labor Costs:","description":"The salaries of highly trained molecular biologists, technicians, and support staff contribute to the overall cost. The availability and demand for skilled personnel in Madagascar can impact these wages."}
- {"item":"Laboratory Overhead:","description":"This includes costs associated with facility rent or ownership, utilities (electricity, water), waste disposal (especially biohazardous waste), and administrative expenses."}
- {"item":"Accreditation and Quality Control:","description":"Laboratories adhering to international quality standards (e.g., ISO 15189) often invest in rigorous quality control measures, which adds to their operational expenses and can influence pricing."}
- {"item":"Location and Accessibility:","description":"Labs in major urban centers like Antananarivo may have slightly different pricing structures compared to those in more remote areas, considering logistical challenges and market demand."}
- {"item":"Urgency of Results:","description":"Expedited or STAT testing services usually come with a premium due to the immediate allocation of resources and potential overtime for staff."}
- {"item":"Volume of Testing:","description":"Larger laboratories performing a high volume of tests may benefit from economies of scale, potentially offering competitive pricing. However, this is not always the case."}
- {"item":"Partnerships and Subsidies:","description":"Some diagnostic services might be subsidized by government programs, NGOs, or research grants, leading to lower costs for specific populations or for certain types of tests."}
Affordable Molecular Diagnostics Labs Options
Affordable molecular diagnostics labs are crucial for increasing access to essential health information. This involves finding laboratories that offer a good balance of cost and quality, and understanding how to leverage their services effectively. Value bundles and cost-saving strategies are key to making these services more accessible.
| Strategy/Bundle | Description | Potential Cost Savings |
|---|---|---|
| Value Bundles | Multi-Test Packages: Labs may offer discounted pricing when multiple related tests are ordered together. This is common for genetic panels or comprehensive screening. | 10-30% reduction compared to individual test pricing. |
| Companion Diagnostics Bundles: When a specific drug requires a companion diagnostic test, some pharmaceutical companies partner with labs to offer bundled pricing. | Often integrated into drug cost or offered at a reduced lab fee. | |
| Preventive Health Packages: Bundles focusing on screening for common diseases (e.g., infectious diseases, certain cancers) can be priced more affordably than ordering tests individually. | 15-25% reduction on average. | |
| Cost-Saving Strategies | Early Bird Discounts: Some labs offer lower prices for samples received within a specific timeframe. | 5-10% reduction for early submission. |
| Bulk Discounts for Clinics/Practices: Healthcare providers ordering a high volume of tests can negotiate lower per-test prices. | Negotiable, can be substantial based on volume. | |
| Out-of-Pocket Discounts: Labs may offer a reduced price for patients paying directly, bypassing insurance complexities. | Varies, but can offer significant savings for uninsured or underinsured patients. | |
| Telehealth Integration: Some labs work with telehealth providers, which might streamline the ordering process and potentially reduce administrative overhead, translating to lower costs. | Indirect savings through streamlined processes. | |
| Comparison Shopping: Actively compare prices and services from multiple accredited labs before committing to an order. | Significant potential savings by choosing the most competitive option. |
Key Considerations for Affordable Molecular Diagnostics Labs
- Accreditation and Quality: Ensure the lab is accredited by recognized bodies (e.g., CLIA in the US, UK NEQAS in the UK). This guarantees reliable and accurate results.
- Test Menu and Specialization: Look for labs that specialize in the types of tests you need. This can sometimes lead to more competitive pricing due to economies of scale.
- Turnaround Time (TAT): While speed is important, faster TATs often come at a premium. Determine your acceptable TAT to avoid unnecessary costs.
- Pricing Transparency: Choose labs that clearly list their prices or offer easy-to-understand quotes. Avoid hidden fees.
- Geographic Location and Shipping: Consider the cost and logistics of shipping samples. Local labs or those with efficient shipping networks can be more cost-effective.
- Patient Assistance Programs: Some labs or manufacturers offer financial assistance programs for eligible individuals.
- Insurance Coverage: Verify if your insurance plan covers the specific molecular diagnostic tests and if the lab is in-network.
Verified Providers In Madagascar
In Madagascar's evolving healthcare landscape, identifying trusted and verified healthcare providers is paramount for individuals seeking quality medical services. Franance Health stands out as a leading organization committed to ensuring the highest standards of care through its rigorous credentialing process. This dedication to verification not only safeguards patient well-being but also builds essential trust between patients and healthcare professionals. Choosing a Franance Health credentialed provider means opting for a healthcare experience built on a foundation of competence, ethical practice, and a commitment to patient-centered care, making them the superior choice for your health needs in Madagascar.
| Credential Aspect | Franance Health Verification Process | Benefit to Patient |
|---|---|---|
| Professional Licensing & Certification | Thorough checks against national and international licensing bodies to confirm current and valid credentials. | Guarantees providers are legally authorized and meet minimum competency requirements. |
| Educational Background | Verification of medical degrees and postgraduate training from recognized institutions. | Ensures a strong academic foundation and specialized knowledge. |
| Clinical Experience & Competence | Assessment of past performance, peer reviews, and potentially practical skill evaluations. | Confirms practical ability and effective application of medical knowledge. |
| Ethical Standards & Disciplinary Records | Background checks for any past disciplinary actions or malpractice claims. | Protects patients by ensuring providers uphold ethical obligations and have no significant negative history. |
| Continuing Medical Education (CME) | Confirmation of ongoing professional development and updated knowledge in their field. | Ensures providers are current with the latest medical advancements and treatments. |
Why Franance Health Credentials Matter
- Ensures adherence to stringent medical standards and best practices.
- Verifies professional qualifications, licenses, and certifications.
- Promotes ethical conduct and patient safety.
- Increases transparency and trust in the healthcare system.
- Facilitates access to competent and reliable medical professionals.
- Reduces the risk of encountering substandard or fraudulent healthcare services.
Scope Of Work For Molecular Diagnostics Labs
This document outlines the Scope of Work (SOW) for molecular diagnostics laboratories, detailing technical deliverables and standard specifications. It covers the essential components required for establishing, operating, and maintaining a high-quality molecular diagnostics facility.
| Section | Technical Deliverables | Standard Specifications/Requirements |
|---|---|---|
| Laboratory Design and Infrastructure | Architectural plans, utility layouts, biosafety level (BSL) compliance. | Minimum BSL-2, with potential for BSL-3 for specific applications. Adequate ventilation, fume hoods, biosafety cabinets, waste disposal systems, dedicated cleanrooms (pre-PCR, post-PCR, sample processing). Electrical, plumbing, and HVAC systems designed for laboratory use. Emergency power backup. |
| Equipment and Instrumentation | List of required instruments, their technical specifications, and performance criteria. | Nucleic acid extraction systems (automated/manual), PCR/qPCR cyclers, digital PCR systems, next-generation sequencing (NGS) platforms, real-time analyzers, centrifuges, biosafety cabinets (Class II or III), incubators, refrigerators, freezers (-20°C, -80°C), water purification systems, pipetting stations (manual/automated), vortex mixers, microplate readers, centrifuges, personal protective equipment (PPE). |
| Reagents and Consumables | Approved vendor list, quality standards for reagents, inventory management plan. | High-purity nucleic acid extraction kits, PCR/qPCR master mixes, primers, probes, dNTPs, enzymes, sterile consumables (tubes, plates, tips), labware, disposables. Reagents must be certified for molecular biology applications. Strict expiry date management and temperature-controlled storage. |
| Test Development and Validation | SOPs for assay development, validation protocols, performance characteristics. | Development and validation of molecular assays for various applications (infectious diseases, genetic disorders, oncology). Validation parameters include accuracy, precision (repeatability, reproducibility), limit of detection (LoD), limit of quantification (LoQ), specificity, linearity, range, interference, and stability. Rigorous documentation of all validation steps. |
| Quality Assurance and Quality Control (QA/QC) | QA/QC plans, control materials, proficiency testing participation, documentation procedures. | Regular QC testing of reagents and instruments. Use of positive and negative controls in every assay run. Internal and external proficiency testing (PT) programs. Documentation of all QC results and corrective actions. Establishment of clear decision limits and alert limits. |
| Data Management and Reporting | Laboratory Information Management System (LIMS) specifications, data security, report formats. | Secure and robust LIMS for sample tracking, test ordering, results reporting, and data archival. Compliance with data privacy regulations (e.g., HIPAA, GDPR). Standardized report templates with clear interpretation of results, including confidence intervals and potential limitations. Audit trails for all data modifications. |
| Personnel and Training | Staffing requirements, competency assessment protocols, training programs. | Qualified personnel including molecular biologists, lab technicians, and bioinformaticians. Comprehensive training program for all staff on SOPs, instrument operation, biosafety, and data analysis. Regular competency assessments and continuing education. |
| Biosafety and Biosecurity | Biosafety manual, waste management protocols, emergency response plan. | Adherence to national and international biosafety guidelines (e.g., CDC, WHO). Detailed protocols for handling biological samples, decontaminating workspaces, and safe disposal of biohazardous waste. Emergency preparedness plan for spills, accidents, and security breaches. Restricted access to authorized personnel. |
| Regulatory Compliance | List of applicable regulations, accreditation requirements, audit readiness. | Compliance with local, national, and international regulatory bodies (e.g., CLIA, CAP, ISO 15189). Obtaining and maintaining necessary licenses and certifications. Preparedness for internal and external audits. Documentation of all regulatory compliance activities. |
| Maintenance and Support | Preventive maintenance schedules, calibration procedures, vendor support agreements. | Regular preventive maintenance and calibration of all equipment according to manufacturer recommendations. Service level agreements (SLAs) with instrument vendors for timely repairs and technical support. Inventory of spare parts for critical instruments. |
Key Areas Covered by the Scope of Work
- Laboratory Design and Infrastructure
- Equipment and Instrumentation
- Reagents and Consumables
- Test Development and Validation
- Quality Assurance and Quality Control (QA/QC)
- Data Management and Reporting
- Personnel and Training
- Biosafety and Biosecurity
- Regulatory Compliance
- Maintenance and Support
Service Level Agreement For Molecular Diagnostics Labs
This Service Level Agreement (SLA) outlines the guaranteed response times and uptime for services provided by [Molecular Diagnostics Lab Name] to [Client Name]. This SLA is effective as of [Start Date] and will remain in effect until terminated by either party in accordance with the terms of the Master Services Agreement.
| Service Category | Guaranteed Response Time | Uptime Guarantee |
|---|---|---|
| Routine Diagnostic Testing (Sample Receipt to Preliminary Report) | Within 8 business hours of sample receipt | 99.5% uptime for reporting and data access systems |
| STAT (Urgent) Diagnostic Testing (Sample Receipt to Preliminary Report) | Within 2 business hours of sample receipt | 99.8% uptime for reporting and data access systems |
| Data Reporting and Access (System Availability) | N/A (Covered by Uptime Guarantee) | 99.9% uptime for all diagnostic data access portals and reporting systems |
| Technical Support and Consultation (Ticket Response) | Within 4 business hours during operational hours ([Lab Operational Hours]) | N/A (Service based on availability) |
Scope of Services Covered
- Routine Diagnostic Testing Services
- STAT (Urgent) Diagnostic Testing Services
- Data Reporting and Access
- Technical Support and Consultation
In-Depth Guidance
Frequently Asked Questions
Phase 02: Execution
Ready when you are
Let's scope your Molecular Diagnostics Labs in Madagascar project in Madagascar.
OEM Approved
54Regions
Scaling healthcare logistics and technical systems across the entire continent.